Topics:
Gastrointestinal Cancers • Medical Oncology
How do you approach the management of borderline resectable pancreatic cancer in patients with superior mesenteric artery vs vein abutment ?
Does the location of the pancreatic mass respective to the major vessels alter initial management (surgery, chemotherapy, radiation, or some combination)?
Answer from: Medical Oncologist at Academic Institution
This is an area where treatment paradigms are in flux. If there is no vascular abutment our usual policy is resection followed by adjuvant treatment. With the augmented response rates being seen with FOLFOXIRI and gemcitabine + nab paclitaxel there is a better chance that tumor shrinkage off of vasc...
Sign in or Register to read more